Results 11 to 20 of about 84,228 (303)
Loss of BAP1 Expression Is Very Rare in Pancreatic Ductal Adenocarcinoma. [PDF]
PLoS ONE, 2016 BACKGROUND:Pancreatic cancer is both common and highly lethal and therefore new biomarkers or potential targets for treatment are needed. Loss of BRCA associated protein-1 (BAP1) expression has been found in up to a quarter of intrahepatic ...
Michael Tayao +9 more
doaj +3 more sources
Pancreatic Ductal Adenocarcinoma: Epidemiology and Risk Factors
Diagnostics, 2021 The number of new cases of pancreatic ductal adenocarcinoma is increasing with a cumulative total of 495,773 cases worldwide, making it the fourteenth most common malignancy.
Jun Ushio +12 more
doaj +2 more sources
Journal of Medical Case Reports, 2021 Background Metastatic spread to the pancreas is a rare event. Renal cell carcinoma represents one possible site of origin of pancreatic metastases. Renal cell carcinoma often metastasizes late and exclusively to the pancreas, suggesting a special role of
Lena Haeberle +6 more
doaj +2 more sources
Surgical Treatment of Pancreatic Ductal Adenocarcinoma
Cancers, 2021 This special issue, “Surgical Treatment of Pancreatic Ductal Adenocarcinoma” contains 13 articles (five original articles, five reviews, and three systematic reviews/meta-analyses) authored by international leaders and surgeons who treat patients with ...
Kongyuan Wei +2 more
exaly +2 more sources
Aquaporins in pancreatic ductal adenocarcinoma
APMIS, 2021 Aquaporins are water channel proteins facilitating passive transport of water across cellular membranes. Aquaporins are over- or ectopically expressed in a multitude of cancers, including pancreatic ductal adenocarcinoma, which is a highly aggressive ...
Lene N. Nejsum +9 more
core +3 more sources
Features of immunophenotype of pancreatic ductal adenocarcinoma
Zaporožskij Medicinskij Žurnal, 2014 Aim. To determine features of immunophenotype of pancreatic ductal adenocarcinoma. Methods and results. At the immunohistochemical research of biopsy and postoperative material of 120 patients with pancreatic ductal adenocarcinoma the expression ...
A. V. Evseyev
doaj +2 more sources
Pancreatic Ductal Adenocarcinoma and Its Variants
Surgical Pathology Clinics, 2016 Pancreatic cancer represents the seventh leading cause of cancer death in the world, responsible for more than 300,000 deaths per year. The most common tumor type among pancreatic cancers is pancreatic ductal adenocarcinoma, an infiltrating neoplasm with
Claudio Luchini +2 more
exaly +2 more sources
Syndecans and Pancreatic Ductal Adenocarcinoma [PDF]
Biomolecules, 2021 Pancreatic Ductal Adenocarcinoma (PDAC) is a fatal disease with poor prognosis because patients rarely express symptoms in initial stages, which prevents early detection and diagnosis. Syndecans, a subfamily of proteoglycans, are involved in many physiological processes including cell proliferation, adhesion, and migration.
Betriu, Nausika +4 more
openaire +4 more sources
Models of pancreatic ductal adenocarcinoma [PDF]
Cancer and Metastasis Reviews, 2021 AbstractAlthough pancreatic cancer remains to be a leading cause of cancer-related deaths in many industrialized countries, there have been major advances in research over the past two decades that provided a detailed insight into the molecular and developmental processes that govern the genesis of this highly malignant tumor type.
Rayane Dennaoui +2 more
openaire +2 more sources
Pancreatic Ductal Adenocarcinoma [PDF]
Mayo Clinic Proceedings, 2017 Pancreatic ductal adenocarcinoma is ranked fourth in cancer-causing deaths. Most cases of pancreatic cancer are advanced and unresectable at the time of diagnosis due to their delayed symptomatic presentation. PET/MR imaging has a high sensitivity and specificity for detecting malignant pancreatic lesions and provides superior soft tissue detail to ...
+5 more sources